Summary
Rottapharm SpA (Rottapharm), a subsidiary of Meda AB is a pharmaceutical company that research, develops, manufactures, markets and distributes clinically proven consumer healthcare products. The company offers pharmaceutical products to therapeutic areas such as cardiology, gastroenterology, gynecology, pediatrics, respiratory system, rheumatology and urology. It provides personal hygiene and personal care products for dermatology, sun protection and hair care. Rottapharm also offers nutraceutical products and dietary supplements. The company operates through its subsidiaries in South America, Africa, Asia and Europe. It has manufacturing facilities in Italy, Spain, India, Germany and Ireland. Rottapharm is headquartered in Monza, Italy.
Rottapharm SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Rottapharm SpA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Rottapharm SpA, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Rottapharm|Madaus Acquires Zyma Brands 11
Private Equity 12
Riverside Acquires Euromed from Meda for USD86.7 Million 12
Rottapharm|Madaus Terminates Discussions To Sell Its 50% Stake To Clessidra Capital And Avista Capital For US$2 Billion 14
Licensing Agreements 15
Rottapharm Madaus Enters Into Licensing Agreement With Edmond Pharma For Mucodox 15
Equity Offering 16
Rottapharm Withdraws IPO for USD614.7 Million 16
Acquisition 18
Meda Acquires Rottapharm from Fidim for USD3 Billion 18
Fidim Acquires Rottapharm Biotech from Rottapharm 20
Rottapharm SpA - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26
List of Tables
Rottapharm SpA, Pharmaceuticals & Healthcare, Key Facts 1
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Rottapharm SpA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Rottapharm SpA, Deals By Therapy Area, 2010 to YTD 2016 8
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Rottapharm|Madaus Acquires Zyma Brands 11
Riverside Acquires Euromed from Meda for USD86.7 Million 12
Rottapharm|Madaus Terminates Discussions To Sell Its 50% Stake To Clessidra Capital And Avista Capital For US$2 Billion 14
Rottapharm Madaus Enters Into Licensing Agreement With Edmond Pharma For Mucodox 15
Rottapharm Withdraws IPO for USD614.7 Million 16
Meda Acquires Rottapharm from Fidim for USD3 Billion 18
Fidim Acquires Rottapharm Biotech from Rottapharm 20
Rottapharm SpA, Key Competitors 21
Rottapharm SpA, Key Employees 22
Rottapharm SpA, Other Locations 23
Rottapharm SpA, Subsidiaries 23
List of Figures
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Rottapharm SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8